Bonovas and Sitaras expressed appropriate concern and tested for publication bias, which
is a serious potential problem in meta-analyses. However, they included only randomized …

Commentary on pravastatin and cancer: need for individual patient data meta-analyses. -
Abstract - Europe PMC Sign in | Create an account https://orcid.org Europe PMC Menu About …

Purpose To assess the influence of pravastatin therapy on cancer morbidity and mortality by
a meta‐analysis of individual patient data (IPD) from three independent Japanese large …

Background: An increase in the incidence of cancer among elderly people assigned to
pravastatin therapy has been reported in a randomized controlled trial; however, this finding …

BACKGROUND: Although the short-term safety of statins is well established, their potential
carcinogenicity in the long term is still being debated. The aim of this study was to …

In a prospective cohort study of postmenopausal women with cancer (Wang et al, 2016), it
was found that current use of statins and other cholesterol-lowering medication was …

Concerns regarding a potential link between statin treatment and increased risk of cancer
were raised following the increased cancer incidence observed in patients treated with …

In their commentary, Drs. Takahashi and Nishibori 1 discuss putative antitumour effects of
statins. However, prospective data suggest that statins actually increase cancer in certain …

Why the interest in lipid-lowering drugs and cancer? This is an old story and dates back to
jeremiads issued in the early days of lipid-lowering drug therapy. Analyses of …

1 Bjerre LM, LeLorier J. Do statins cause cancer? A meta-analysis of large randomised
clinical trials. Am J Med 2001; 110: 716–23. 2 Shepherd J, Blauw GJ, Murphy MB, et al, on …